{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:29:48Z","timestamp":1783531788527,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbadis.2019.165605","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T02:21:00Z","timestamp":1573784460000},"page":"165605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Agonist-induced 4-1BB activation prevents the development of Sj\u04e7gren's syndrome-like sialadenitis in non-obese diabetic mice"],"prefix":"10.1016","volume":"1866","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Ra","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.165605_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1196\/annals.1384.003","article-title":"Autoimmune diseases and Sjogren\u2019s syndrome: an autoimmune exocrinopathy","volume":"1098","author":"Fox","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"46","key":"10.1016\/j.bbadis.2019.165605_bb0010","article-title":"Primary Sjogren\u2019s Syndrome: health experiences and predictors of health quality among patients in the United States","volume":"7","author":"Segal","year":"2009","journal-title":"Health Qual. Life Outcomes"},{"issue":"9","key":"10.1016\/j.bbadis.2019.165605_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren\u2019s syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2019.165605_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2017.04.003","article-title":"Innate immunity in Sjogren\u2019s syndrome","volume":"182","author":"Kiripolsky","year":"2017","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bbadis.2019.165605_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2014.02.009","article-title":"Early events in Sjogren\u2019s syndrome pathogenesis: the importance of innate immunity in disease initiation","volume":"67","author":"Kramer","year":"2014","journal-title":"Cytokine."},{"key":"10.1016\/j.bbadis.2019.165605_bb0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2741\/2187","article-title":"Sjogren\u2019s syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies","volume":"12","author":"Nguyen","year":"2007","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.bbadis.2019.165605_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren\u2019s syndrome: contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.bbadis.2019.165605_bb0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/kez072","article-title":"Aspirin triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjogren\u2019s syndrome mouse model","volume":"58","author":"Dean","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2019.165605_bb0045","doi-asserted-by":"crossref","first-page":"45525","DOI":"10.1038\/srep45525","article-title":"AT-RvD1 promotes resolution of inflammation in NOD\/ShiLtJ mice","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2019.165605_bb0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand. J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2019.165605_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren\u2019s syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/labinvest.2010.164","article-title":"IL17: potential therapeutic target in Sjogren\u2019s syndrome using adenovirus-mediated gene transfer","volume":"91","author":"Nguyen","year":"2011","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.bbadis.2019.165605_bb0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sjogren\u2019s syndrome","volume":"74","author":"Lin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2019.165605_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar3348","article-title":"Disturbance of cytokine networks in Sjogren\u2019s syndrome","volume":"13","author":"Youinou","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"3\u20134","key":"10.1016\/j.bbadis.2019.165605_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaut.2009.09.009","article-title":"Sjogren syndrome: advances in the pathogenesis from animal models","volume":"33","author":"Chiorini","year":"2009","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.bbadis.2019.165605_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0b013e32832eba21","article-title":"Pathogenesis of Sjogren\u2019s syndrome","volume":"21","author":"Nikolov","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2019.165605_bb0085","article-title":"T cell-associated cytokines in the pathogenesis of Sjogren\u2019s syndrome","author":"Jin","year":"2013","journal-title":"J. Clin. Cell. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren\u2019s syndrome: an old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"5","key":"10.1016\/j.bbadis.2019.165605_bb0095","doi-asserted-by":"crossref","first-page":"C1191","DOI":"10.1152\/ajpcell.00144.2008","article-title":"Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line","volume":"295","author":"Baker","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2019.165605_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/978-0-387-89520-8_8","article-title":"4-1BB as a therapeutic target for human disease","volume":"647","author":"Lee","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0105","first-page":"31","article-title":"Immunotherapy with agonistic anti-CD137: two sides of a coin","volume":"1","author":"Sun","year":"2004","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/db06-0793","article-title":"Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes","volume":"56","author":"Irie","year":"2007","journal-title":"Diabetes."},{"issue":"3","key":"10.1016\/j.bbadis.2019.165605_bb0115","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.168.3.1457","article-title":"Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis","volume":"168","author":"Sun","year":"2002","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bbadis.2019.165605_bb0120","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.4049\/jimmunol.179.11.7295","article-title":"Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling","volume":"179","author":"Elpek","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165605_bb0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2015.00117","article-title":"4-1BB agonists: multi-potent potentiators of tumor immunity","volume":"5","author":"Bartkowiak","year":"2015","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-065X.2009.00765.x","article-title":"Immune regulation by 4-1BB and 4-1BBL: complexities and challenges","volume":"229","author":"Wang","year":"2009","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.bbadis.2019.165605_bb0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/cmi.2014.90","article-title":"Costimulatory molecules as vaccine adjuvants: to 4-1BB or not to 4-1BB?","volume":"12","author":"Rahman","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2019.165605_bb0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1078-0432.CCR-17-1847","article-title":"Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27-dependent pathway","volume":"24","author":"Bartkowiak","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbadis.2019.165605_bb0145","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1167\/iovs.07-0153","article-title":"Absence of 4 1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice","volume":"48","author":"Vinay","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2019.165605_bb0150","doi-asserted-by":"crossref","first-page":"39105","DOI":"10.1038\/srep39105","article-title":"Endogenous programmed death ligand-1 restrains the development and onset of Sjgren\u2019s syndrome in non-obese diabetic mice","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2019.165605_bb0155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/labinvest.2016.141","article-title":"Pathogenic role of endogenous TNF-alpha in the development of Sjogren\u2019s-like sialadenitis and secretory dysfunction in non-obese diabetic mice","volume":"97","author":"Zhou","year":"2017","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.bbadis.2019.165605_bb0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0022034513483315","article-title":"Type I interferon receptor deficiency prevents murine Sjogren\u2019s syndrome","volume":"92","author":"Szczerba","year":"2013","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2019.165605_bb0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0714.2012.01181.x","article-title":"Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling","volume":"42","author":"Nandula","year":"2013","journal-title":"J. Oral Pathol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391930328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391930328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:54:27Z","timestamp":1760417667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391930328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S092544391930328X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165605","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonist-induced 4-1BB activation prevents the development of Sj\u04e7gren's syndrome-like sialadenitis in non-obese diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165605"}}